Posted on May 23, 20245/23/24
Integrated Delivery Networks (IDNs): Driving Change in Drug Access and Utilization
Posted on May 21, 20245/21/24
Real-World Insights: Effectiveness and Safety of Crizotinib in ROS1-Rearranged NSCLC
Posted on May 3, 20245/3/24
Transforming Systematic Literature Reviews: Leveraging AI for Efficiency and Rigor
Posted on April 30, 20244/30/24
Decoding EMA’s Blueprint on Real-World Evidence
Posted on March 27, 20243/27/24
Growing EVERSANA’s Value & Evidence Global Footprint with the Additions of Monique Martin, Pamela Vo and Deepika Thakur
Posted on February 14, 20242/14/24
Excel in Market Access Success: Key Considerations for Leveraging Your Evidence
Posted on January 30, 20241/30/24
Empowering Success: EVERSANA’s Value & Evidence Team Guides Clients Through CMS Drug Negotiations Under the Inflation Reduction Act
Posted on January 22, 20241/22/24